Organon & Co
852 hedge funds and large institutions have $6.53B invested in Organon & Co in 2022 Q2 according to their latest regulatory filings, with 131 funds opening new positions, 202 increasing their positions, 360 reducing their positions, and 84 closing their positions.
112% more call options, than puts
Call options by funds: $33.1M | Put options by funds: $15.6M
56% more first-time investments, than exits
New positions opened: 131 | Existing positions closed: 84
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
4% more funds holding
Funds holding: 818 → 852 (+34)
1.58% more ownership
Funds ownership: 74.98% → 76.56% (+1.6%)
2% less capital invested
Capital invested by funds: $6.63B → $6.53B (-$101M)
44% less repeat investments, than reductions
Existing positions increased: 202 | Existing positions reduced: 360
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Mawer Investment Management
Calgary,
Alberta, Canada
|
+$89.4M |
| 2 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$36.8M |
| 3 |
Morgan Stanley
New York
|
+$35.4M |
| 4 |
State Street
Boston,
Massachusetts
|
+$34.9M |
| 5 |
LSV Asset Management
Chicago,
Illinois
|
+$23.1M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$74.3M |
| 2 |
AQR Capital Management
Greenwich,
Connecticut
|
-$35.5M |
| 3 |
Goldman Sachs
New York
|
-$22.3M |
| 4 |
SSM
Sound Shore Management
Greenwich,
Connecticut
|
-$22M |
| 5 |
Millennium Management
New York
|
-$17.6M |
OGN Hedge Fund Activity: Q2 2022 in Review
852 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Organon & Co (OGN) for Q2 2022, worth a combined $6.53B — down 1.5% from $6.63B a quarter earlier.
Buyers outnumbered sellers: 131 funds opened new OGN positions and 84 closed out — a net gain of 47 holders — while 202 added to existing stakes and 360 trimmed.
The largest buyer was Mawer Investment Management, adding an estimated $89.4M. The largest seller was Wellington Management Group, exiting entirely with an estimated $74.3M sold.
- 852 institutional investors held Organon & Co (OGN) as of Q2 2022, up from 818 in Q1 2022.
- Funds reported $6.53B of Organon & Co stock for Q2 2022, down 1.5% quarter-over-quarter.
- 131 funds opened new Organon & Co positions in Q2 2022 and 84 closed out, a net change of +47 holders.
- The largest Organon & Co buyer in Q2 2022 was Mawer Investment Management, an estimated $89.4M added.
- The largest Organon & Co seller in Q2 2022 was Wellington Management Group, an estimated $74.3M sold.
Based on aggregated 13F filings for Q2 2022.